Squarepoint Ops LLC Immuno Gen, Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $712,674 - $1.71 Million	-57,197 Reduced 75.88%	18,179 $539,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $282,660 - $1.51 Million	75,376 New	75,376 $1.42 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $486,008 - $674,002	-106,815 Reduced 30.52%	243,195 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1.05 Million - $1.51 Million	233,781 Added 201.14%	350,010 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $443,271 - $810,552	-140,721 Reduced 54.77%	116,229 $523,000

Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $833,860 - $1.46 Million	195,742 Added 319.8%	256,950 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $30,333 - $47,895	-6,386 Reduced 9.45%	61,208 $454,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $255,397 - $335,272	-50,876 Reduced 42.94%	67,594 $383,000
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $897,774 - $1.33 Million	-155,056 Reduced 56.69%	118,470 $781,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $398,697 - $645,889	61,338 Added 28.91%	273,526 $2.22 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $426,998 - $884,002	115,405 Added 119.24%	212,188 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $215,538 - $305,502	62,475 Added 182.1%	96,783 $348,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $28,585 - $45,977	-8,610 Reduced 20.06%	34,308 $158,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $514,390 - $1.65 Million	-242,637 Reduced 84.97%	42,918 $146,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $711,609 - $1.83 Million	-316,271 Reduced 52.55%	285,555 $1.46 Million
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.39 $1.24 Million - $1.9 Million	559,035 Added 1306.43%	601,826 $1.46 Million
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $466,902 - $855,987	-259,390 Reduced 85.84%	42,791 $93,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $31,631 - $77,568	13,125 Added 4.54%	302,181 $819,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $785,462 - $1.93 Million	199,356 Added 222.25%	289,056 $1.39 Million
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $9,460 - $12,386	-1,100 Reduced 1.21%	89,700 $849,000
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $472,192 - $602,640	49,600 Added 120.39%	90,800 $883,000
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $276,040 - $533,540	41,200 New	41,200 $433,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account